查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1291477

HPV检测和PAP检测市场：2023-2028年全球行业趋势、份额、规模、增长、机会和预测

HPV Testing and PAP Test Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

市场概况：

2022年，全球HPV检测和PAP检测市场规模达到40亿美元。展望未来，IMARC集团预计到2028年市场规模将达到56亿美元，在2023-2028年期间表现出5.92%的增长率（CAGR）。

人乳头瘤病毒（HPV）是一种性传播感染（STI），会导致宫颈、口咽、阴茎和外阴的癌症。它可以在各种测试和程序的支持下被检测出来，如HPV和帕帕尼古拉乌（PAP）测试。这些评估包括对标本的显微镜观察和宫颈癌、头颈癌筛查。其中，HPV测试被部署用于评估在生殖器疣发展之前存在的人类乳头瘤病毒，而PAP测试则用于确定细胞的变化和宫颈中存在的异常细胞。

HPV检测和PAP检测市场趋势：

由于乳头瘤病毒的存在，宫颈癌的发病率越来越高，特别是在成年人群中，这促进了对新型的、技术先进的、具有成本效益的HPV和PAP筛查的需求，这也是推动市场增长的主要因素之一。与此相呼应，引入机器辅助的、无血浆和无细胞的脱氧核糖核酸（DNA）筛查，在早期阶段检测和监测感染HPV的癌症的治疗反应，是另一个增长诱导因素。由于冠状病毒病（COVID-19）大流行的突然爆发，主要参与者不断进行临床试验、开发和推出产品，如易于使用的家用HPV筛查测试，正在为他们提供市场竞争优势。其他因素，如医疗部门的快速扩张，以及政府机构和非政府组织（NGO）为提高人们对宫颈癌病因以及进行HPV和PAP测试的好处的认识而采取的许多有利倡议，正在为市场创造积极的前景。

本报告中回答的关键问题：

  • 迄今为止，全球HPV检测和PAP检测市场的表现如何，在未来几年将如何表现？
  • COVID-19对全球HPV检测和PAP检测市场的影响是什么？
  • 主要的区域市场是什么？
  • 基于测试类型的市场细分是什么？
  • 基于产品的市场细分是什么？
  • 基于应用的市场细分是什么？
  • 基于终端用户的市场细分是什么？
  • 行业价值链中的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球HPV检测和PAP检测市场的结构是什么，谁是主要参与者？
  • 该行业的竞争程度如何？

目录

第一章：前言

第二章：范围和方法

  • 研究的目标
  • 利益相关者
  • 数据来源
    • 主要来源
    • 二级来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球HPV检测和PAP检测市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：按测试类型分類的市场

  • HPV测试
    • 市场趋势
    • 市场预测
  • 巴氏试验
    • 市场趋势
    • 市场预测
  • 联合检测
    • 市场趋势
    • 市场预测

第7章 ：按产品分類的市场

  • 仪器
    • 市场趋势
    • 市场预测
  • 耗材
    • 市场趋势
    • 市场预测
  • 服务
    • 市场趋势
    • 市场预测

第8章：按应用分類的市场

  • 子宫颈癌筛查
    • 市场趋势
    • 市场预测
  • 阴道癌筛查
    • 市场趋势
    • 市场预测

第九章：按终端用户分類的市场

  • 医院和诊所
    • 市场趋势
    • 市场预测
  • 实验室
    • 市场趋势
    • 市场预测
  • 诊断中心
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第十章：按地区分類的市场

  • 北美洲
    • 美国
      • 市场趋势
      • 市场预测
    • 加拿大
      • 市场趋势
      • 市场预测
  • 亚太地区
    • 中国
      • 市场趋势
      • 市场预测
    • 日本
      • 市场趋势
      • 市场预测
    • 印度
      • 市场趋势
      • 市场预测
    • 韩国
      • 市场趋势
      • 市场预测
    • 澳大利亚
      • 市场趋势
      • 市场预测
    • 印尼
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 欧洲
    • 德国
      • 市场趋势
      • 市场预测
    • 法国
      • 市场趋势
      • 市场预测
    • 英国
      • 市场趋势
      • 市场预测
    • 意大利
      • 市场趋势
      • 市场预测
    • 西班牙
      • 市场趋势
      • 市场预测
    • 俄罗斯
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场趋势
      • 市场预测
    • 墨西哥
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 中东和非洲
    • 市场趋势
    • 按国家分類的市场
    • 市场预测

第十一章 ：SWOT分析

  • 概述
  • 优势
  • 劣势
  • 机会
  • 威胁

第十二章 ：价值链分析

第十三章 ：波特斯五力分析

  • 概述
  • 买方的讨价还价能力
  • 供应商的讨价还价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十四章：价格分析

第十五章 ：竞争格局

  • 市场结构
  • 主要参与者
  • 主要参与者的概况
    • Abbott Laboratories
    • Arbor Vita Corporation
    • AstraZeneca plc
    • Becton Dickinson and Company
    • Biocon Limited
    • bioMerieux SA
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Hologic Inc.
    • NURX Inc. (Thirty Madison Inc.)
    • Qiagen N.V.
    • Quest Diagnostics Incorporated
    • Seegene Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A5889

Market Overview:

The global HPV testing and PAP test market size reached US$ 4.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.6 Billion by 2028, exhibiting a growth rate (CAGR) of 5.92% during 2023-2028. 

Human papillomavirus (HPV) is a sexually transmitted infection (STI) that causes cancer of the cervix, oropharynx, penis, and vulva. It can be detected with the support of various tests and procedures, such as HPV and Papanicolaou (PAP) test. These assessments comprise microscopic observation of specimens and cervical, head and neck cancer screening. Amongst these, HPV tests are deployed for assessing the presence of human papillomavirus that precede the development of genital warts, whereas PAP tests are used for determining changes in the cell and the presence of abnormal cells in cervices. 

HPV Testing and PAP Test Market Trends:

The increasing prevalence of cervical cancer, especially amongst the adult demographics. due to presence of papillomavirus is facilitating the need for novel, technologically advanced, and cost-effective HPV and PAP screening, which is one of the major factors primarily driving the market growth. In line with this, the introduction of machine-assisted, plasma- and cell-free deoxyribonucleic acid (DNA) screenings to detect and monitor the treatment response of HPV-infected cancers at the early phase is acting as another growth-inducing factor. This is further supported by the continuous clinical trials, developments, and product launches by key players, such as the easy-to-use home HPV screening test, on account of the sudden outbreak of coronavirus disease (COVID-19) pandemic, is providing them with a competitive edge in the market. Other factors, such as the rapid expansion in the healthcare sector and the numerous favorable initiatives undertaken by the government bodies and the non-governmental organizations (NGOs) for sensitizing people regarding the causes of cervical cancer and the benefits of having HPV and PAP tests are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global HPV testing and PAP test market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on test type, product, application and end user.

Breakup by Test Type:

  • HPV Test
  • Pap Test
  • Co-testing

Breakup by Product:

  • Instruments
  • Consumables
  • Services

Breakup by Application:

  • Cervical Cancer Screening
  • Vaginal Cancer Screening

Breakup by End User:

  • Hospitals and Clinics
  • Laboratories
  • Diagnostic Centers
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arbor Vita Corporation, AstraZeneca plc, Becton Dickinson and Company, Biocon Limited, bioMerieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., NURX Inc. (Thirty Madison Inc.), Qiagen N.V., Quest Diagnostics Incorporated, Seegene Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global HPV testing and PAP test market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global HPV testing and PAP test market?
  • What are the key regional markets?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global HPV testing and PAP test market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global HPV Testing and PAP Test Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Test Type

  • 6.1  HPV Test
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Pap Test
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Co-testing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7   Market Breakup by Product

  • 7.1  Instruments
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Consumables
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Services
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8   Market Breakup by Application

  • 8.1  Cervical Cancer Screening
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Vaginal Cancer Screening
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9   Market Breakup by End User

  • 9.1  Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2  Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3  Diagnostic Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4  Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10  Market Breakup by Region

  • 10.1  North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2  Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3  Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4  Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5  Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11  SWOT Analysis

  • 11.1  Overview
  • 11.2  Strengths
  • 11.3  Weaknesses
  • 11.4  Opportunities
  • 11.5  Threats

12  Value Chain Analysis

13  Porters Five Forces Analysis

  • 13.1  Overview
  • 13.2  Bargaining Power of Buyers
  • 13.3  Bargaining Power of Suppliers
  • 13.4  Degree of Competition
  • 13.5  Threat of New Entrants
  • 13.6  Threat of Substitutes

14  Price Analysis

15  Competitive Landscape

  • 15.1  Market Structure
  • 15.2  Key Players
  • 15.3  Profiles of Key Players
    • 15.3.1  Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2  Arbor Vita Corporation
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3  AstraZeneca plc
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4  Becton Dickinson and Company
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5  Biocon Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6  bioMerieux SA
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7  Danaher Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8  F. Hoffmann-La Roche AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9  Hologic Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10  NURX Inc. (Thirty Madison Inc.)
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11  Qiagen N.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12  Quest Diagnostics Incorporated
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
    • 15.3.13  Seegene Inc.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
    • 15.3.14  Thermo Fisher Scientific Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: HPV Testing and PAP Test Market: Major Drivers and Challenges
  • Figure 2: Global: HPV Testing and PAP Test Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: HPV Testing and PAP Test Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: HPV Testing and PAP Test Market: Breakup by Test Type (in %), 2022
  • Figure 5: Global: HPV Testing and PAP Test Market: Breakup by Product (in %), 2022
  • Figure 6: Global: HPV Testing and PAP Test Market: Breakup by Application (in %), 2022
  • Figure 7: Global: HPV Testing and PAP Test Market: Breakup by End User (in %), 2022
  • Figure 8: Global: HPV Testing and PAP Test Market: Breakup by Region (in %), 2022
  • Figure 9: Global: HPV Testing and PAP Test (HPV Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: HPV Testing and PAP Test (HPV Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: HPV Testing and PAP Test (Pap Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: HPV Testing and PAP Test (Pap Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: HPV Testing and PAP Test (Co-testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: HPV Testing and PAP Test (Co-testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: HPV Testing and PAP Test (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: HPV Testing and PAP Test (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: HPV Testing and PAP Test (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: HPV Testing and PAP Test (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: HPV Testing and PAP Test (Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: HPV Testing and PAP Test (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: HPV Testing and PAP Test (Cervical Cancer Screening) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: HPV Testing and PAP Test (Cervical Cancer Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: HPV Testing and PAP Test (Vaginal Cancer Screening) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: HPV Testing and PAP Test (Vaginal Cancer Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: HPV Testing and PAP Test (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: HPV Testing and PAP Test (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: HPV Testing and PAP Test (Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: HPV Testing and PAP Test (Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: HPV Testing and PAP Test (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: HPV Testing and PAP Test (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: HPV Testing and PAP Test (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: HPV Testing and PAP Test (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: North America: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: North America: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: United States: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: United States: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Canada: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Canada: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Asia-Pacific: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Asia-Pacific: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: China: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: China: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Japan: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Japan: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: India: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: India: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: South Korea: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: South Korea: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Australia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Australia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Indonesia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Indonesia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Europe: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Europe: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Germany: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Germany: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: France: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: France: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: United Kingdom: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: United Kingdom: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Italy: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Italy: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Spain: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Spain: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Russia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Russia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Latin America: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Latin America: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Brazil: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Brazil: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Mexico: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Mexico: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Middle East and Africa: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Middle East and Africa: HPV Testing and PAP Test Market: Breakup by Country (in %), 2022
  • Figure 81: Middle East and Africa: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Global: HPV Testing and PAP Test Industry: SWOT Analysis
  • Figure 83: Global: HPV Testing and PAP Test Industry: Value Chain Analysis
  • Figure 84: Global: HPV Testing and PAP Test Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: HPV Testing and PAP Test Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: HPV Testing and PAP Test Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 3: Global: HPV Testing and PAP Test Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 4: Global: HPV Testing and PAP Test Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: HPV Testing and PAP Test Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: HPV Testing and PAP Test Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: HPV Testing and PAP Test Market: Competitive Structure
  • Table 8: Global: HPV Testing and PAP Test Market: Key Players